Del Carmen Jeffrey

Catalyst Pharmaceuticals, Inc. ยท Chief Commercial Officer

Del Carmen Jeffrey is listed in public filings as officer: Chief Commercial Officer. This Del Carmen Jeffrey insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Catalyst Pharmaceuticals, Inc. (CPRX). Investors use Del Carmen Jeffrey's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Catalyst Pharmaceuticals, Inc.CPRX--14.3k sharesGrant / ExerciseDec 29, 2025Disclosure amount unavailable3.8k shares----
Catalyst Pharmaceuticals, Inc.CPRX--18.2k sharesGrant / ExerciseDec 29, 2025Disclosure amount unavailable8.7k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Catalyst Pharmaceuticals, Inc.CPRX--9.5k sharesGrant / ExerciseDec 8, 2025Disclosure amount unavailable2.5k shares----
Catalyst Pharmaceuticals, Inc.CPRX--12k sharesGrant / ExerciseDec 8, 2025Disclosure amount unavailable8k shares----
Catalyst Pharmaceuticals, Inc.CPRX$92k4k sharesSellNov 26, 2025$256.2K11k shares$23.33--
Catalyst Pharmaceuticals, Inc.CPRX$63k14.9k sharesGrant / ExerciseNov 26, 2025$46.2K11k shares$4.21--
Catalyst Pharmaceuticals, Inc.CPRX--4k sharesGrant / ExerciseNov 21, 2025Disclosure amount unavailable1.6k shares----
Catalyst Pharmaceuticals, Inc.CPRX--5.6k sharesGrant / ExerciseNov 21, 2025Disclosure amount unavailable5.6k shares----
Catalyst Pharmaceuticals, Inc.CPRX$24M1M sharesGrant / ExerciseNov 20, 2025$2.4M106.9k shares$22.77--
Catalyst Pharmaceuticals, Inc.CPRX--1.1M sharesGrant / ExerciseNov 20, 2025Disclosure amount unavailable32.3k shares----
Catalyst Pharmaceuticals, Inc.CPRX$030.4k sharesSellMar 3, 2025$696.4K30.4k shares$22.89--
Catalyst Pharmaceuticals, Inc.CPRX--30.4k sharesGrant / ExerciseFeb 14, 2025Disclosure amount unavailable3.1k shares----
Catalyst Pharmaceuticals, Inc.CPRX--33.5k sharesGrant / ExerciseFeb 14, 2025Disclosure amount unavailable10.7k shares----
Catalyst Pharmaceuticals, Inc.CPRX--22.9k sharesGrant / ExerciseDec 27, 2024Disclosure amount unavailable3.8k shares----
Catalyst Pharmaceuticals, Inc.CPRX--26.7k sharesGrant / ExerciseDec 27, 2024Disclosure amount unavailable8.7k shares----
Catalyst Pharmaceuticals, Inc.CPRX--18.1k sharesGrant / ExerciseDec 9, 2024Disclosure amount unavailable2.4k shares----
Catalyst Pharmaceuticals, Inc.CPRX--20.4k sharesGrant / ExerciseDec 9, 2024Disclosure amount unavailable8k shares----
Catalyst Pharmaceuticals, Inc.CPRX$20M941.6k sharesGrant / ExerciseNov 21, 2024$2.9M137.6k shares$21.12--
Catalyst Pharmaceuticals, Inc.CPRX--958.4k sharesGrant / ExerciseNov 21, 2024Disclosure amount unavailable16.8k shares----